Caremark will sell a genetically engineered drug.
- Share via
Within two weeks, the Newport Beach health-care company will begin dispensing its new drug Protropin, a human growth hormone made by Genentech of South San Francisco. The drug is used to treat dwarfism, a condition affecting up to 15,000 children. Under the agreement, Caremark will distribute Protropin nationwide to patients not served by hospital pharmacies; Genentech sells directly to the hospital pharmacies. Last week, Protropin became the second biotechnology drug to receive Food and Drug Administration approval for sale in the United States.
More From the Los Angeles Times
Podcasts
The latest effort is coming from the L.A. County Board of Supervisors. They just announced a $3 million program in conjunction with some nonprofits groups to test and clean the soil at homes still standing in the areas impacted by the Eaton Fire.
The Hillside Strangler murders terrorized Los Angeles in the late 1970s. The killers were a pair of sadistic cousins. One confessed. The other was set to stand trial—until L.A. prosecutors flinched.
Hosts Fidel Martínez and Suzy Exposito sit down with Dr. Vanessa J. Díaz, professor of Chicano and Latino Studies at Loyola Marymount University and co-author of P FKN R: How Bad Bunny Became the Global Voice of Puerto Rican Resistance.
